Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital
Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital
This is a prospective, open lable studies conducted in 115 hospital to compare between
 thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and
 safety of endovascular treatment in basilar artery occlusion stroke patients
Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar
 artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per
 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as
 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried
 in groups of patients with vertebrobasilar territory infarction but evidence based was not
 cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety
 of endovascular treatment in basilar artery occlusion stroke patients
Inclusion Criteria:

 -  Patients admit to 115 hospital in 24h of Basilar Artery Occlusion Stroke

 -  NIHSS > 4 points

 Exclusion Criteria:

 -  Patients refuse to participate in studies

 -  Patients with contraindication of either rTPA or thromboectomy